Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: lujan r. J Crohns Colitis. 2022 Jun 24;16(5):778-785. doi: 10.1093/ecco-jcc/jjab204. J Crohns Colitis. 2022. PMID: 34791083
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Ollech J, Zittan E, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: lujan r. J Crohns Colitis. 2022 Jun 24;16(5):796-803. doi: 10.1093/ecco-jcc/jjab210. J Crohns Colitis. 2022. PMID: 34904163
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
Lev-Tzion R, Focht G, Lujan R, Mendelovici A, Friss C, Greenfeld S, Kariv R, Ben-Tov A, Matz E, Nevo D, Barak-Corren Y, Dotan I, Turner D. Lev-Tzion R, et al. Among authors: lujan r. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1263-e1282. doi: 10.1016/j.cgh.2021.12.026. Epub 2021 Dec 23. Clin Gastroenterol Hepatol. 2022. PMID: 34954338 Free PMC article.
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN).
Atia O, Focht G, Lujan R, Ledder O, Greenfeld S, Kariv R, Dotan I, Yanai H, Gabay H, Balicer R, Haklai Z, Nevo D, Turner D. Atia O, et al. Among authors: lujan r. J Pediatr Gastroenterol Nutr. 2022 Jun 1;74(6):788-793. doi: 10.1097/MPG.0000000000003422. Epub 2022 Feb 22. J Pediatr Gastroenterol Nutr. 2022. PMID: 35192577
Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
Ledder O, Harel S, Lujan R, Friss C, Orlanski-Meyer E, Yogev D, Loewenberg Weisband Y, Greenfeld S, Kariv R, Lederman N, Matz E, Schwartz D, Focht G, Dotan I, Turner D. Ledder O, et al. Among authors: lujan r. Inflamm Bowel Dis. 2024 Jan 5;30(1):1-8. doi: 10.1093/ibd/izad034. Inflamm Bowel Dis. 2024. PMID: 36917191
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
Lujan R, Buchuk R, Focht G, Yogev D, Greenfeld S, Ben-Tov A, Weisband YL, Lederman N, Matz E, Ben Horin S, Dotan I, Nevo D, Turner D. Lujan R, et al. Gastroenterology. 2024 May;166(5):815-825.e22. doi: 10.1053/j.gastro.2024.01.041. Epub 2024 Feb 6. Gastroenterology. 2024. PMID: 38331205
231 results